| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-09-29 | 2009-07-31 | N-Q | Roche Holding Ag | RHHBY.OB | CH | Medical-Drugs | 268,205 | New Holding | 268,205 | 100 % | - | - | - | - % | | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Roche Holding Ag |
| 2009-09-29 | 2009-07-31 | N-Q | Bayer Ag | BAYZF.OB | US | Chemicals-Diversified | 148,217 | New Holding | 148,217 | 100 % | - | - | - | - % | | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Bayer Ag |
| 2009-09-29 | 2009-07-31 | N-Q | Merck Kgaa | MKGAF.PK | DE | Medical-Drugs | 81,364 | New Holding | 81,364 | 100 % | - | - | - | - % | | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Merck Kgaa |
| 2009-09-29 | 2009-07-31 | N-Q | Wright Medical Group Inc | WMGI | FR | Medical Products | 435,318 | New Holding | 435,318 | 100 % | $7,840,077 | $8,005,498 | $165,421 | 2.10 % | $165,421 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Wright Medical Group Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Amag Pharmaceuticals Inc | AMAG | BE | Medical-Biomedical/Gene | 125,518 | New Holding | 125,518 | 100 % | $5,667,138 | $4,989,341 | $-677,797 | -11.96 % | $-677,797 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Amag Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Thermo Fisher Scientific Inc | TMO | US | Instruments-Scientific | 863,098 | New Holding | 863,098 | 100 % | $37,639,704 | $40,185,843 | $2,546,139 | 6.76 % | $2,546,139 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Thermo Fisher Scientific Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Nobel Biocare Holding Ag | NBCHF.PK | CH | Medical Products | 153,472 | New Holding | 153,472 | 100 % | - | - | - | - % | | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Nobel Biocare Holding Ag |
| 2009-09-29 | 2009-07-31 | N-Q | Incyte Corp Ltd | INCY | US | Medical-Biomedical/Gene | 488,713 | New Holding | 488,713 | 100 % | $3,303,700 | $3,689,783 | $386,083 | 11.68 % | $386,083 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Incyte Corp Ltd |
| 2009-09-29 | 2009-07-31 | N-Q | Cadence Pharmaceuticals Inc | CADX | US | Medical-Drugs | 475,217 | New Holding | 475,217 | 100 % | $5,217,883 | $4,134,388 | $-1,083,495 | -20.76 % | $-1,083,495 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Cadence Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Array Biopharma Inc | ARRY | US | Medical-Drugs | 541,465 | New Holding | 541,465 | 100 % | $1,321,175 | $1,099,174 | $-222,001 | -16.80 % | $-222,001 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Array Biopharma Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Auxilium Pharmaceuticals Inc | AUXL | US | Medical-Drugs | 144,750 | New Holding | 144,750 | 100 % | $5,014,140 | $5,056,118 | $41,978 | 0.83 % | $41,978 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Auxilium Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Biomarin Pharmaceutical Inc | BMRN | US | Therapeutics | 799,695 | New Holding | 799,695 | 100 % | $14,658,409 | $13,570,824 | $-1,087,585 | -7.41 % | $-1,087,585 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Biomarin Pharmaceutical Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Cigna Corp | CI | US | Life/Health Insurance | 530,945 | New Holding | 530,945 | 100 % | $15,185,027 | $15,944,278 | $759,251 | 5.00 % | $759,251 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Cigna Corp |
| 2009-09-29 | 2009-07-31 | N-Q | Baxter International Inc | BAX | US | Medical Products | 445,992 | New Holding | 445,992 | 100 % | $25,327,886 | $24,230,745 | $-1,097,140 | -4.33 % | $-1,097,140 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Baxter International Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Aryx Therapeutics Inc | ARYX | US | Medical-Biomedical/Gene | 498,000 | New Holding | 498,000 | 100 % | $1,618,500 | $1,225,080 | $-393,420 | -24.30 % | $-393,420 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Aryx Therapeutics Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Mckesson Corp | MCK | US | Health Care Cost Contain | 340,391 | New Holding | 340,391 | 100 % | $20,008,183 | $21,485,480 | $1,477,297 | 7.38 % | $1,477,297 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Mckesson Corp |
| 2009-09-29 | 2009-07-31 | N-Q | Covidien Ltd | COV | BM | Medical Products | 527,040 | New Holding | 527,040 | 100 % | $22,594,205 | $24,059,376 | $1,465,171 | 6.48 % | $1,465,171 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Covidien Ltd |
| 2009-09-29 | 2009-07-31 | N-Q | Dexcom Inc | DXCM | US | Medical Instruments | 405,470 | New Holding | 405,470 | 100 % | $3,243,760 | $2,947,767 | $-295,993 | -9.12 % | $-295,993 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Dexcom Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Davita Inc | DVA | US | Dialysis Centers | 361,530 | New Holding | 361,530 | 100 % | $20,310,755 | $21,312,194 | $1,001,438 | 4.93 % | $1,001,438 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Davita Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Quest Diagnostics Incde | DGX | US | Medical Labs And Testing Srv | 181,578 | New Holding | 181,578 | 100 % | $9,489,266 | $10,558,761 | $1,069,494 | 11.27 % | $1,069,494 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Quest Diagnostics Incde |
| 2009-09-29 | 2009-07-31 | N-Q | Pharmasset Inc | VRUS | US | Medical-Drugs | 127,400 | New Holding | 127,400 | 100 % | $2,676,674 | $2,504,684 | $-171,990 | -6.42 % | $-171,990 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Pharmasset Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Resmed Inc | RMD | US | Respiratory Products | 165,802 | New Holding | 165,802 | 100 % | $7,459,432 | $8,331,551 | $872,119 | 11.69 % | $872,119 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Resmed Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Rigel Pharmaceuticals Inc | RIGL | US | Medical-Drugs | 201,608 | New Holding | 201,608 | 100 % | $1,659,234 | $1,568,510 | $-90,724 | -5.46 % | $-90,724 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Rigel Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Insulet Corp | PODD | US | Patient Monitoring Equip | 319,047 | New Holding | 319,047 | 100 % | $3,563,755 | $3,940,230 | $376,475 | 10.56 % | $376,475 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Insulet Corp |
| 2009-09-29 | 2009-07-31 | N-Q | Dendreon Corp | DNDN | US | Therapeutics | 82,123 | New Holding | 82,123 | 100 % | $2,273,165 | $2,300,265 | $27,101 | 1.19 % | $27,101 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Dendreon Corp |
| 2009-09-29 | 2009-07-31 | N-Q | Amil Participacoes Sa | AMIL3.SA | BR | Life/Health Insurance | 1,382,700 | New Holding | 1,382,700 | 100 % | - | - | - | - % | | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Amil Participacoes Sa |
| 2009-09-29 | 2009-07-31 | N-Q | Csl Ltdaustralia | CMXHF.OB | AU | Medical-Biomedical/Gene | 427,218 | New Holding | 427,218 | 100 % | - | - | - | - % | | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Csl Ltdaustralia |
| 2009-09-29 | 2009-07-31 | N-Q | Becton Dickinson And Co | BDX | US | Medical Products | 316,553 | New Holding | 316,553 | 100 % | - | - | - | - % | | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Becton Dickinson And Co |
| 2009-09-29 | 2009-07-31 | N-Q | Omnicare Inc | OCR | US | Pharmacy Services | 370,487 | New Holding | 370,487 | 100 % | $8,487,857 | $8,613,823 | $125,966 | 1.48 % | $125,966 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Omnicare Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Alcon Inc | ACL | CH | Optical Supplies | 157,945 | New Holding | 157,945 | 100 % | $22,132,833 | $22,943,091 | $810,258 | 3.66 % | $810,258 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Alcon Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Drogasil Sa | DROG3.SA | BR | Retail-Drug Store | 861,426 | New Holding | 861,426 | 100 % | - | - | - | - % | | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Drogasil Sa |
| 2009-09-29 | 2009-07-31 | N-Q | Immucor Inc | BLUD | US | Diagnostic Equipment | 434,327 | New Holding | 434,327 | 100 % | $7,678,901 | $8,152,318 | $473,416 | 6.16 % | $473,416 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Immucor Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dentsply International Inc | XRAY | US | Dental Supplies And Equip | 312,849 | New Holding | 312,849 | 100 % | $10,793,291 | $10,280,218 | $-513,072 | -4.75 % | $-513,072 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Dentsply International Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Hologic Inc | HOLX | US | X-Ray Equipment | 464,448 | New Holding | 464,448 | 100 % | $7,714,481 | $6,683,407 | $-1,031,075 | -13.36 % | $-1,031,075 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Hologic Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Osi Pharmaceuticals Inc | OSIP | US | Medical-Drugs | 184,835 | New Holding | 184,835 | 100 % | $6,565,339 | $6,060,740 | $-504,600 | -7.68 % | $-504,600 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Osi Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Cvscaremark Corp | CVS | US | Retail-Drug Store | 723,365 | New Holding | 723,365 | 100 % | $26,091,776 | $22,887,269 | $-3,204,507 | -12.28 % | $-3,204,507 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Cvscaremark Corp |
| 2009-09-29 | 2009-07-31 | N-Q | Allergan Incunited States | AGN | US | Medical-Drugs | 336,771 | New Holding | 336,771 | 100 % | $19,195,947 | $19,741,516 | $545,569 | 2.84 % | $545,569 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Allergan Incunited States |
| 2009-09-29 | 2009-07-31 | N-Q | Celgene Corp | CELG | US | Medical-Biomedical/Gene | 442,626 | New Holding | 442,626 | 100 % | $24,393,119 | $24,304,594 | $-88,525 | -0.36 % | $-88,525 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Celgene Corp |
| 2009-09-29 | 2009-07-31 | N-Q | Genzyme Corp | GENZ | US | Medical-Biomedical/Gene | 404,094 | New Holding | 404,094 | 100 % | $23,013,153 | $20,224,905 | $-2,788,249 | -12.11 % | $-2,788,249 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Genzyme Corp |
| 2009-09-29 | 2009-07-31 | N-Q | Gilead Sciences Inc | GILD | US | Therapeutics | 1,030,039 | New Holding | 1,030,039 | 100 % | $47,876,213 | $47,783,509 | $-92,704 | -0.19 % | $-92,704 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Gilead Sciences Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Hospira Inc | HSP | US | Drug Delivery Systems | 263,647 | New Holding | 263,647 | 100 % | $11,816,659 | $12,359,771 | $543,113 | 4.59 % | $543,113 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Hospira Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Johnson And Johnson | JNJ | US | Medical Products | 597,715 | New Holding | 597,715 | 100 % | $36,418,775 | $37,243,622 | $824,847 | 2.26 % | $824,847 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Johnson And Johnson |
| 2009-09-29 | 2009-07-31 | N-Q | Health Net Inc | HNT | US | Medical-Hmo | 310,677 | New Holding | 310,677 | 100 % | $4,858,988 | $6,247,714 | $1,388,726 | 28.58 % | $1,388,726 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Health Net Inc |
| 2009-09-29 | 2009-07-31 | N-Q | United Therapeutics Corp | UTHR | US | Therapeutics | 109,109 | New Holding | 109,109 | 100 % | $5,317,973 | $4,900,085 | $-417,887 | -7.85 % | $-417,887 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of United Therapeutics Corp |
| 2009-09-29 | 2009-07-31 | N-Q | Varian Medical Systems Inc | VAR | US | Medical Products | 280,131 | New Holding | 280,131 | 100 % | $11,782,310 | $12,776,775 | $994,465 | 8.44 % | $994,465 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Varian Medical Systems Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Medco Health Solutions Inc | MHS | US | Pharmacy Services | 291,192 | New Holding | 291,192 | 100 % | $16,321,312 | $17,940,339 | $1,619,028 | 9.91 % | $1,619,028 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Medco Health Solutions Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Express Scripts Inc | ESRX | US | Pharmacy Services | 283,390 | New Holding | 283,390 | 100 % | $22,081,749 | $24,113,655 | $2,031,906 | 9.20 % | $2,031,906 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Express Scripts Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Biogen Idec Inc | BIIB | US | Medical-Biomedical/Gene | 187,514 | New Holding | 187,514 | 100 % | $9,640,095 | $8,696,899 | $-943,195 | -9.78 % | $-943,195 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Biogen Idec Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Amerigroup Corp | AGP | US | Medical-Hmo | 226,083 | New Holding | 226,083 | 100 % | $5,104,954 | $5,120,780 | $15,826 | 0.31 % | $15,826 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Amerigroup Corp |
| 2009-09-29 | 2009-07-31 | N-Q | Unitedhealth Group Inc | UNH | US | Medical-Hmo | 520,252 | New Holding | 520,252 | 100 % | $13,360,071 | $14,858,397 | $1,498,326 | 11.21 % | $1,498,326 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Unitedhealth Group Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Aetna Inc | AET | US | Medical-Hmo | 338,386 | New Holding | 338,386 | 100 % | $9,559,405 | $9,610,162 | $50,758 | 0.53 % | $50,758 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Aetna Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Abbott Laboratories | ABT | US | Medical-Drugs | 784,685 | New Holding | 784,685 | 100 % | $38,528,034 | $42,090,503 | $3,562,470 | 9.24 % | $3,562,470 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Abbott Laboratories |
| 2009-09-29 | 2009-07-31 | N-Q | Amgen Inc | AMGN | US | Medical-Biomedical/Gene | 703,859 | New Holding | 703,859 | 100 % | $42,555,315 | $38,979,711 | $-3,575,604 | -8.40 % | $-3,575,604 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Amgen Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Wellpoint Inc | WLP | US | Medical-Hmo | 450,057 | New Holding | 450,057 | 100 % | $22,178,809 | $23,465,972 | $1,287,163 | 5.80 % | $1,287,163 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Wellpoint Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Zimmer Holdings Inc | ZMH | US | Medical Products | 310,724 | New Holding | 310,724 | 100 % | $16,654,806 | $17,686,410 | $1,031,604 | 6.19 % | $1,031,604 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Zimmer Holdings Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Medtronic Inc | MDT | US | Medical Instruments | 876,073 | New Holding | 876,073 | 100 % | $32,537,351 | $34,710,012 | $2,172,661 | 6.67 % | $2,172,661 | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Medtronic Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Wyeth | WYE | US | Medical-Drugs | 399,766 | New Holding | 399,766 | 100 % | $19,448,616 | - | - | - % | | | | | | | News Article | History of Aim Investment Funds - Aim Developing Markets Fund Ownership Of Wyeth |
![]() |
| |
Note: All amounts are based on price of stock at date reported versus the current price! They do not represent actual profit/loss!
There has been no adjustmentsfor splits! |
| Note: All amounts in USD, converted using Intrabank Exchange Rate on Date Reported/Today |
|
Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and may be inaccurate!
|
| Note: For security reasons, only (A-Z,a-z,0-9,space,period,colon,comma,forward slash,at) can be inputed - all others are stripped automatically! |
|
Copyright © 2007 All rights reserved. Please see our Terms of Use.
|
|
![]() |
RSS feed for Aim Investment Funds - Aim Developing Markets Fund